Literature DB >> 21529739

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

Rachel R Huxley1, Kristian B Filion, Suma Konety, Alvaro Alonso.   

Abstract

Atrial fibrillation (AF) is 1 of the most clinically diagnosed cardiac disturbances but little is known about its risk factors. Previous epidemiologic studies have reported on the association between diabetes mellitus (DM) and subsequent risk of AF, with inconsistent results. The aim of this study was to conduct a meta-analysis of published studies to reliably determine the direction and magnitude of any association between DM and AF. A systematic review and meta-analysis was conducted. PubMed and EMBASE were searched to identify prospective cohort and case-control studies that had reported on the association between DM and other measurements of glucose homeostasis with incident AF by April 2010. Studies conducted in primarily high-risk populations and participants in randomized controlled trials were excluded. Seven prospective cohort studies and 4 case-control studies with information on 108,703 cases of AF in 1,686,097 subjects contributed to this analysis. The summary estimate indicated that patients with DM had an approximate 40% greater risk of AF compared to unaffected patients (relative risk [RR] 1.39, 95% confidence interval [CI] 1.10 to 1.75, p for heterogeneity <0.001). After correcting for publication bias, the RR was 1.34 (1.07 to 1.68). Studies that had adjusted for multiple risk factors reported a smaller effect estimate compared to age-adjusted studies (RR 1.24, 95% CI 1.06 to 1.44, vs 1.70, 1.29 to 2.22, p for heterogeneity = 0.053). The population-attributable fraction of AF owing to DM was 2.5% (95% CI 0.1 to 3.9). In conclusion, DM is associated with an increased risk of subsequent AF but the mechanisms that may underpin the relation between DM and AF remain speculative.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21529739      PMCID: PMC3181495          DOI: 10.1016/j.amjcard.2011.03.004

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  Acute alcohol intake and QT dispersion in healthy subjects.

Authors:  Huseyin Uyarel; Cagdas Ozdol; Ahmet Murat Gencer; Ertan Okmen; Nese Cam
Journal:  J Stud Alcohol       Date:  2005-07

Review 2.  Bias in location and selection of studies.

Authors:  M Egger; G D Smith
Journal:  BMJ       Date:  1998-01-03

3.  Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease.

Authors:  Mohammad-Reza Movahed; Mehrtash Hashemzadeh; M Mazen Jamal
Journal:  Int J Cardiol       Date:  2005-12-07       Impact factor: 4.164

4.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  Lars Frost; Lone Juul Hune; Peter Vestergaard
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

5.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

6.  Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study.

Authors:  Hiroshi Watanabe; Naohito Tanabe; Toru Watanabe; Dawood Darbar; Dan M Roden; Shigeru Sasaki; Yoshifusa Aizawa
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

Review 7.  Possible molecular mechanisms by which angiotensin II type 1 receptor blockers (ARBs) prevent the development of atrial fibrillation in insulin resistant patients.

Authors:  S-I Yamagishi; T Matsui; K Nakamura
Journal:  Horm Metab Res       Date:  2008-09-15       Impact factor: 2.936

8.  Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.

Authors:  Annika Rosengren; Paul J Hauptman; Georg Lappas; Lars Olsson; Lars Wilhelmsen; Karl Swedberg
Journal:  Eur Heart J       Date:  2009-03-20       Impact factor: 29.983

9.  Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation.

Authors:  Gregory A Nichols; Kyndaron Reinier; Sumeet S Chugh
Journal:  Diabetes Care       Date:  2009-10       Impact factor: 19.112

10.  Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects.

Authors:  Odd Erik Johansen; Ellen Brustad; Steve Enger; Arnljot Tveit
Journal:  Cardiovasc Diabetol       Date:  2008-09-28       Impact factor: 9.951

View more
  136 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).

Authors:  Omid Fatemi; Eugene Yuriditsky; Costas Tsioufis; Demetrios Tsachris; Timothy Morgan; Jan Basile; Thomas Bigger; William Cushman; David Goff; Elsayed Z Soliman; Abraham Thomas; Vasilios Papademetriou
Journal:  Am J Cardiol       Date:  2014-07-30       Impact factor: 2.778

3.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

4.  Cost Effectiveness of Subsidizing Fruit and Vegetable Purchases Through the Supplemental Nutrition Assistance Program.

Authors:  Sung Eun Choi; Hilary Seligman; Sanjay Basu
Journal:  Am J Prev Med       Date:  2017-01-30       Impact factor: 5.043

5.  [Diabetes, prediabetes and cardiovascular risk].

Authors:  B Stratmann; D Tschoepe
Journal:  Internist (Berl)       Date:  2015-06       Impact factor: 0.743

Review 6.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

7.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

Review 8.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

9.  Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy.

Authors:  Rohit Malhotra; Kenneth C Bilchick; John P DiMarco
Journal:  Am J Cardiol       Date:  2013-11-09       Impact factor: 2.778

10.  Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial.

Authors:  Alvaro Alonso; Judy L Bahnson; Sarah A Gaussoin; Alain G Bertoni; Karen C Johnson; Cora E Lewis; Marion Vetter; Christos S Mantzoros; Robert W Jeffery; Elsayed Z Soliman
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.